Ramiah Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Sell
1,865
-103
-5% -$22.2K 0.36% 39
2026
Q1
$428K Sell
1,968
-63
-3% -$14K 2.86% 15
2025
Q4
$464K Sell
2,031
-320
-14% -$72.9K 0.4% 45
2025
Q3
$544K Buy
2,351
+67
+3% +$13.6K 0.48% 34
2025
Q2
$424K Buy
+2,284
New +$424K 0.46% 46
2020
Q3
Sell
-2,617
Closed -$257K 76
2020
Q2
$257K Buy
+2,617
New +$230K 0.27% 64

Other funds holding ABBV

Ramiah Investment Group's ABBV Position: Q2 2026 in Review

Ramiah Investment Group reduced its AbbVie (ABBV) stake by 5.2% in Q2 2026, selling an estimated $22.2K and leaving 1,865 shares worth $469K. The position accounts for 0.36% of the portfolio, ranked #39.

Ramiah Investment Group first reported a position in ABBV in Q2 2020 and has held it in 6 quarters since. The position peaked at $544K in Q3 2025. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ramiah Investment Group held 1,865 shares of AbbVie worth $469K as of Q2 2026.
  • Ramiah Investment Group sold 103 AbbVie shares in Q2 2026, an estimated $22.2K.
  • AbbVie made up 0.36% of Ramiah Investment Group's portfolio in Q2 2026, its #39 holding.
  • Ramiah Investment Group first reported a position in AbbVie in Q2 2020 and has held it in 6 quarters since.
  • Ramiah Investment Group's AbbVie position peaked at $544K in Q3 2025.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.